Retina Labs is actively monitoring the evolving COVID-19 (Coronavirus) situation and has taken all necessary and proactive steps to ensure the safety of the patients we serve, our employees and customers.
Retina Labs Launches Pioneering Teleconsultation Platform to Offer Virtual Eye Care During COVID-19 Crisis
Improving Health Outcomes for People Living With Diabetes
Diabetic retinopathy is the leading cause of blindness. Fewer than 50% of people with diabetes in the U.S. receive screening examinations at appropriate intervals. Early detection and prompt treatment can reduce vision loss by up to 95%.
Retina Labs clinic-based and in-home screening programs offer primary care providers, health systems and health plans a clinically proven approach to prevent blindness, close critical diabetes care gaps, improve outcomes and lower healthcare costs.
Discover Retina Labs Teleretinal
iVision is Retina Labs proprietary, end-to-end teleophthalmology platform used for screening of chronic eye diseases such as diabetic retinopathy, glaucoma, macular degeneration and retinopathy of prematurity.
Our cloud-based teleophthalmology solution streamlines clinical and administrative screening management workflows, from scheduling, image capture and diagnosis to automated reporting and patient referral.
Cloud-Based | HIPAA Compliant & Secure | Works With Most Retinal Cameras | Integrates With Your EMR System
Uncover the Benefits of Teleretinal Screening
Teleretinal screening is a clinically proven and effective means to increase retinal exam compliance rates, lower healthcare costs and improve outcomes. By integrating a diabetic retinopathy screening service into their practice, primary care providers can provide this essential component of routine diabetic care.
Increase Quality Scores
Take control of your HEDIS quality measures and quickly improve compliance rates.
Improve Diabetes Care
Identify patients with early signs of eye disease, risk factors for hyperglycemia, hypertension, dyslipidemia and systemic health issues.
Detect diabetic retinopathy in its earliest stages and ensure that patients are referred to specialists in a timely manner.
Grow your practice through recurring reimbursement revenues and payer-based incentives.
Trusted by Primary Care Providers, Health Systems & Health Plans
Diabetic Retinopathy is the Leading Cause of Preventable Blindness
By integrating a diabetic retinopathy screening service into their practice, healthcare providers diabetes care and outcomes. Patients with diabetes can receive a quick, convenient and non-invasive retinal exam at their next doctor’s visit and have their results on the same day.
Listen to Our Clients
“A much larger number of patients were screened by local healthcare providers, completely eliminating displacement costs. Not only where patients satisfied with the care they received, the cost efficiencies generated through the use of iVision demonstrate the importance of telemedicine.”
Telehealth Program Manager
“iVision allows us to provide highly convenient, quality eye care to remote communities, while eliminating costs associated with transferring patients to urban centres for routine screenings. Having worked with iVision for this and other screening programs, I can attest to its ease-of-use and accuracy.”
Antoinette Ghanem, Senior Telehealth Advisor
“We are committed to providing comprehensive diabetes car. Our partnership with Retina Labs is helping us detect diabetic retinopathy, so we can hopefully prevent vision loss in our patient population.”
Marilyn Sumerford, Executive Director of Access Family Health